BRTX
BRTX
NASDAQ · Biotechnology

Biorestorative Therapies Inc

$0.37
+0.00 (+0.11%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +6,973.0% upside
Low Target $18.72
Average Target $26.17
High Target $39.89
Current Price $0.37
Current
$0.37
Target
$26.17
$18.72 $26.17 avg $39.89
Scenario Analysis
Bear Case
$18.72
4,959.5%
Low target
Base Case
$26.17
+6,973.0%
Avg target
Bull Case
$39.89
+10,681.1%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$1.89
-80.4% from high
52-Week Low
$0.16
+132.3% from low
Target vs 52W High
$26.17
+1,284.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.6%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -38.5%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.0%